Anthem Updates Coverage Policy for Breast Reconstruction Surgery

Anthem Blue Cross Blue Shield has updated its coverage policy to include synthetic surgical mesh in breast reconstruction surgeries, aligning with Cigna as one of the few major U.S. health insurers to offer this coverage.

Anthem's decision, influenced by a wave of scrutiny and investigative reporting on insurance denials for breast cancer treatment, marks a significant policy shift. In its updated guidelines, Anthem now recognizes synthetic meshes like GalaFLEX as necessary for breast reconstruction surgery. Previously, these devices were deemed investigational due to a lack of supporting evidence regarding their effectiveness. With recent studies and new data, as highlighted by a company spokesperson, Anthem emphasizes its commitment to evidence-based policy updates. The policy change comes amidst rising advocacy from both patients and healthcare providers, reflecting a progressive step in breast cancer care.

Industry and Regulatory Insights

Surgical mesh, although commonplace in breast reconstruction by plastic surgeons, remains off-label in terms of FDA approval, posing coverage challenges for insurers. Anthem's prior positions mirrored industry hesitancy, using this classification to deny coverage. However, the updated policy demonstrates a response to increasing demand and advocacy efforts.

Advocacy groups and medical professionals, including Dr. Alicia Billington and organizations like the American Society of Plastic Surgeons, celebrate Anthem's move while also advocating for enhanced legislation. They aim to fortify the Women’s Health & Cancer Rights Act for broader coverage of essential breast cancer treatments.

Implications for Policyholders

This strategic shift holds positive potential for policyholders and future patients. Beth Clark, a breast cancer survivor, shared her optimism regarding the announcement, having previously faced coverage challenges that impacted her treatment plan. With these revisions, stakeholders anticipate fewer barriers in accessing necessary reconstructive procedures, benefiting individuals like Clark and others in similar situations.